Epidemiology of hepatitis C viral infection in Faisalabad, Pakistan: A retrospective study (2010-2012)

African Health Sciences

Volumn 14, Issue 4, 2014, Pages 810-815

  Maan, Muhammad Arif ^a   Fatma, Hussain ^b   Muhammad, Jamil ^c  

^a Punjab Medical College Sexually Transmitted Infections (STIs) clinic District Headquarter (DHQ) hospital Department of Dermatology   (Pakistan)

^b University of Agriculture   (Pakistan)

^c District Headquarter Hospital   (Pakistan)

Author keywords

Blood transfusion; Hepatitis C; Virus

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EDUCATIONAL STATUS; FEMALE; HEALTH CENTER; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL; HUMAN; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PAKISTAN; POPULATION RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SEXUAL BEHAVIOR; ADOLESCENT; AGED; BLOOD; BLOOD TRANSFUSION; HEPACIVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; URBAN POPULATION; YOUNG ADULT;

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAKISTAN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION; YOUNG ADULT;

EID: 84921691937     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v14i4.6     Document Type: Article

References (29)

1. Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. Scientific World Journal 2012; 719494. http://www.ncbi.nlm.nih.gov/pubmed/22629189
2. Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and structural analysis of 3' untranslated region of hepatitis C virus, genotype 3a, from Pakistani isolates. Hepat Mon 2013; 13(5):e8390. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732663
3. Köse S, Kuzucu L, Gözaydın A, Yılmazer T. Prevalence of hepatitis B and C viruses among asylum seekers in Izmir. J Immigr Minor Health 2013.
4. Nelson PK, Mathers BM, Cowie B, Hagan H, Jarlais DD, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378(9791): 571-83. doi: 10.1016/S0140-6736(11)61097-0
5. Adjei AA, Quaye IKE, Armah HB, Hesse IFA, Gbagbo F, Ampofo WK, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol 2006;55: 593-97. http://jmm.sgmjournals.org/content/55/5/593.short
6. Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: multi-city study. Addiction 2006; 101(2): 252-66. DOI: 10.1111/j.1360-0443.2006.01317.x
7. Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public health 2008;122(10):990-1003. http://www.sciencedirect.com/science/article/pii/S0033350608000401.
8. Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus 2009; 7(4): 293. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782806
9. Johnston L, Saumtally A, Corceal S, Mahadoo I, Oodally F. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: Findings from a population size estimation and respondent driven sampling survey. Int J Drug Policy 2011; 22(4):252-58. http://www.sciencedirect.com/science/article/pii/S0955395911000685
10. Nagalo MB, Sanou M, Bisseye C, Kaboré MI, Nebie YK, Kienou K, et al. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus 2011; 9(4): 419-24. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200412/
11. Zhao YS, Su SL, Lv CX, Zhang XF, Lin L, Sun XG, et al. Sero-prevalence of hepatitis C, hepatitis B virus and syphilis in HIV-1 infected patients in Shandong. Int J STD & AIDS 2012; 23: 639-43. doi: 10.1258/ijsa.2012.011411
12. Calleja-Panero JL, Llop-Herrera E, Ruiz-Moraga M, de-la-Revilla-Negro J, Calvo-Bonacho E, Pons-Renedo F, et al. Prevalence of viral hepatitis (B and C) serological markers in healthy working population. Rev Espn enferm dig 2013; 105(5), 249-54. http://www.ncbi.nlm.nih.gov/pubmed/23971655
13. Johnston LG, Corceal S. Unexpectedly high injection drug use, HIV and hepatitis C prevalence among female sex workers in the Republic of Mauritius. AIDS Behav 2013; 17(2):574-84. http://www.ncbi.nlm.nih.gov/pubmed/22851154
14. Johnston LG, Vaillant TC, Dolores Y, Vales HM. HIV, hepatitis B/C and syphilis prevalence and risk behaviors among gay, transsexuals and men who have sex with men, Dominican Republic. Int J STD AIDS 2013; 24(4):313-21. http://www.ncbi.nlm.nih.gov/pubmed/23970664
15. Nzaji MK, Ilunga BK. A study of the prevalence of infectious markers in blood donors in rural areas. The case of Kamina hospital. Sante publique 2013; 25(2): 213-17. http://europepmc.org/abstract/MED/23964546
16. Tun W, Vu L, Adebajo SB, Abiodun L, Sheehy M, Karlyn A, et al. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria. Int J STD AIDS 2013; 24(8):619-25. http://www.ncbi.nlm.nih.gov/pubmed/23970571
17. Zohrabyan L, Sultanov L, Demianenko E, Vagaitseva N, Malkin J. P3. 097 Socio-demographic characteristics and drug related high risk behaviour in people who inject drugs (PWID) Recently diagnosed HIV positive in Barnaul, Russia. Sex Transm Infec 2013; 89(Suppl 1), A177-A178. doi:10.1136/sextrans-2013-051184.0556
18. Gasim GI, Murad IA, Adam I. Hepatitis B and C virus infections among pregnant women in Arab and African countries. J Infect Dev Ctries 2013; 7(08):566-78. doi: 10.3855/jidc.3243
19. Noubiap JJN, Joko YWA, Nansseu JRN, Tene UG, Siaka C. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis 2013; 17(10):e832-e837. http://www.sciencedirect.com/science/article/pii/S120197121201329X
20. Gacche RN, Kaid AM. Epidemiology of viral hepatitis B and C infections in ibb city, Yemen. Hepat Mon 2012; 12(7): 460-62. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437458/
21. Zuberi SJ. Seroepidemiology of HBV/HCV in Pakistan. Int J Hepatol Commun 1996; 5(1):19-26. http://www.sciencedirect.com/science/article/pii/S0928434696820068
22. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infec Diseases 2009; 13(1):9-19. http://www.sciencedirect.com/science/article/pii/S1201971208014203
23. Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, et al. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic. Sex transm infect 2009; 85(Suppl 2), 217-222. http://sti.bmj.com/content/85/Suppl_2/ii17.short
24. Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis 2010; 14(Suppl 3): e60-e66. http://www.sciencedirect.com/science/article/pii/S1201971210000305
25. Ahmad N, Asgher M, Shafique M, Qureshi JA. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Saudi Med J 2007; 28 (3):390-95. http://www.ncbi.nlm.nih.gov/pubmed/17334466
26. Maan MA, Hussain F, Iqbal J, Akhtar SJ. Sexually transmitted infections in Pakistan. Annals Saudi Med 2011; 31(3):263-69. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119966
27. Brian JM, Alward WLM, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: Relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151 (4):599-603. http://www.ncbi.nlm.nih.gov/pubmed/3973412
28. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003; 39(6):1036-41. http://www.ncbi.nlm.nih.gov/pubmed/14642623
29. Paladino N, Fainboim H, Theiler G, Schroder T, Muñoz AE, Flores AC, et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol 2006; 80:9144-50. http://jvi.asm.org/content/80/18/9144.short